You have 9 free searches left this month | for more free features.

Condition

Healthy (3)

Rheumatoid Arthritis (1)

Overall Status

Not yet recruiting (2)

Completed (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (3)

phase 2 (1)

Sponsor

Eli Lilly and Company (4)

Collaborator

Rigel Pharmaceuticals (1)

Intervention

ly3871801 (4)

placebo (2)

dextromethorphan (1)

methotrexate (1)

midazolam (1)

repaglinide (1)

warfarin (1)

Study Documents

Intervention Type

drug (4)

Funder Type

Industry (4)

Study Type

Interventional (4)

ly3871801

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Healthy Trial in Cypress (LY3871801, Placebo)

Not yet recruiting

Healthy

LY3871801
Placebo

Cypress, California

Altasciences Clinical Los Angeles, Inc

Jul 18, 2023

Healthy Trial in Dallas (LY3871801, Methotrexate, Warfarin)

Recruiting

Healthy

LY3871801
+5 more

Dallas, Texas

Covance Dallas

Dec 26, 2022

Healthy Trial in Singapore (LY3871801)

Completed

Healthy

LY3871801

Singapore, Singapore

Lilly Centre for Clinical Pharmacology

Mar 17, 2022

Rheumatoid Arthritis Trial in Worldwide (LY3871801, Placebo)

Not yet recruiting

Rheumatoid Arthritis

LY3871801
Placebo

Woodland Hills, California
+46 more

May 10, 2023